| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 716260 | Null | 0.00457614317494024 | 0.41535862 |
| NSC 718728 | 5-[2-(2,5-Dimethoxyphenyl)ethynyl]-2-methoxyphenyl-N- [2-(4-fluorophenyl)ethyl]carboxamide | 0.00457614317494024 | 0.38454185 |
| NSC 727212 | 11-[2'-N-Aminopropyl)-aminoethylidene]-5,6-dihydro-5-oxo-2,3 -dimethoxy-6-methyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoq uinoline | 0.00457614317494024 | 0.51233457 |
| NSC 728037 | 2-[(3,4-dicloro)anilino]-3-phenyl-5,7-diamino quinoxaline | 0.00457614317494024 | 0.43412991 |
| NSC 731201 | ethyl 6,7-dichloro-3-phenyl-2-quinoxalincarboxylate 1,4-dioxide | 0.00457614317494024 | 0.23432543 |
| NSC 734562 | 6-(3-Aminopropyl)-9-bromo-5,6-dihydro-3-nitro-5,11-dioxo-11H -indeno[1,2-c]isoquinoline Hydrochloride | 0.00457614317494024 | 0.32723934 |
| NSC 736164 | pyrazoline derivative | 0.00457614317494024 | 0.44699555 |
| NSC 756169 | GSK317314A | 0.00457614317494024 | 0.30021034 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.00457614317494024 | 0.41311818 |
| NSC 79563 | 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine | 0.00457614317494024 | 0.27376357 |